Literature DB >> 8885866

Defect in rearrangement of the most 5' TCR-J alpha following targeted deletion of T early alpha (TEA): implications for TCR alpha locus accessibility.

I Villey1, D Caillol, F Selz, P Ferrier, J P de Villartay.   

Abstract

To address the role of the TEA germline transcription, which initiates upstream of the TCR-J alpha S, in the regulation of TCR-J alpha locus accessibility, we created a mouse in which this region has been removed by homologous recombination. Normal development of T alpha beta cells and the expression of other TCR alpha germline transcripts in TEA-/- mice ruled out an exclusive role for TEA in the overall accessibility of the J alpha cluster. However, the rearrangement of the most 5' J alpha (J alpha 61 to J alpha 53) was severely impaired, indicating that TEA may control the DNA accessibility of a particular J alpha window. Moreover, the relative usage of every J alpha segment was affected. These results are consistent with TEA acting as a "rearrangement-focusing" element, targeting the primary waves of V alpha-J alpha recombination to the most 5' J alpha S in an ongoing TCR-J alpha rearrangement model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885866     DOI: 10.1016/s1074-7613(00)80259-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  53 in total

1.  Regulation of V(D)J recombination by transcriptional promoters.

Authors:  M L Sikes; C C Suarez; E M Oltz
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  The tight interallelic positional coincidence that distinguishes T-cell receptor Jalpha usage does not result from homologous chromosomal pairing during ValphaJalpha rearrangement.

Authors:  F Davodeau; M Difilippantonio; E Roldan; M Malissen; J L Casanova; C Couedel; J F Morcet; M Merkenschlager; A Nussenzweig; M Bonneville; B Malissen
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 3.  Regulated T-cell development: a victim of multiple conspiracies.

Authors:  A Hayday; D Gibbons
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

4.  T cell receptor (TCR) alpha/delta locus enhancer identity and position are critical for the assembly of TCR delta and alpha variable region genes.

Authors:  Craig H Bassing; Robert E Tillman; Barbara B Woodman; David Canty; Robert J Monroe; Barry P Sleckman; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

5.  Ordered assembly of the V(D)J synaptic complex ensures accurate recombination.

Authors:  Jessica M Jones; Martin Gellert
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

6.  Highly diverse TCRα chain repertoire of pre-immune CD8⁺ T cells reveals new insights in gene recombination.

Authors:  Raphael Genolet; Brian J Stevenson; Laurent Farinelli; Magne Osterås; Immanuel F Luescher
Journal:  EMBO J       Date:  2012-02-28       Impact factor: 11.598

Review 7.  Recent insights into the transcriptional control of the Tcra/Tcrd locus by distant enhancers during the development of T-lymphocytes.

Authors:  Cristina Hernández-Munain
Journal:  Transcription       Date:  2015

8.  PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes.

Authors:  José Yélamos; Yolanda Monreal; Luis Saenz; Enrique Aguado; Valérie Schreiber; Rubén Mota; Teodomiro Fuente; Alfredo Minguela; Pascual Parrilla; Gilbert de Murcia; Elena Almarza; Pedro Aparicio; Josiane Ménissier-de Murcia
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

9.  Regulation of T cell receptor alpha gene assembly by a complex hierarchy of germline Jalpha promoters.

Authors:  Abbas Hawwari; Cheryl Bock; Michael S Krangel
Journal:  Nat Immunol       Date:  2005-04-03       Impact factor: 25.606

10.  Revision of T cell receptor {alpha} chain genes is required for normal T lymphocyte development.

Authors:  Ching-Yu Huang; Barry P Sleckman; Osami Kanagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.